12/16/2025 01:00
Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services, starting with high-yield exosome development using Esco Aster’s cell line platform. The technical reports of process, analytical, and formulation development, exosome drug loading, GMP engineering runs, and stability studies supported Shine...

AFP Joins the New Phase of the German-language Platform Against Disinformation, GADMO 2.0

Three years after its launch, GADMO (the German-Austrian Digital Media Observatory) — the largest German-language fact-checking network bringing together journalists and researchers — is entering a new phase aimed at reaching a wider audience, with the support of the European Commission.

Three years after its launch, GADMO (the German-Austrian Digital Media Observatory) — the largest German-language fact-checking network bringing together journalists and researchers — is entering a new phase aimed at reaching a wider audience, with the support of the European Commission.
Subscribe to